Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Relapsed or Plateau-Phase Multiple Myeloma
NCT00259740Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2005
- Primary completion
- Aug 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of denosumab in multiple myeloma (MM), sponsored by Amgen. Started Nov 2005; status: completed.
02
Drugs
denosumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00259740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259740.